Paradigm Biocapital Advisors LP

Holdings History for Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS)

Symbol: MRUS on Nasdaq
Investment type: Equity / Common Shares, Euro 0.09 nominal value per share
Latest Disclosed Shares Owned: 4,673,770 shares
Security Ownership %: 6.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Paradigm BioCapital Advisors LP ownership in Merus N.V. Common Shares, Euro 0.09 nominal value per share (MRUS)

14 Nov 2025 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,673,770 shares of Merus N.V. Common Shares, Euro 0.09 nominal value per share (MRUS). This represents 6.2% ownership of the company. In their previous filing dated 10 Apr 2025, Paradigm Biocapital Advisors LP had reported owning 3,554,059 shares, indicating an increase of +32%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Paradigm BioCapital Advisors LP	6.2%	+22%	$440,035,446	4,673,770	+1,119,711	+32%	$94.15	13G/A	30 Sep 2025	14 Nov 2025, 16:32
Paradigm BioCapital Advisors LP	5.1%		$140,598,574	3,554,059			$39.56	13G	03 Apr 2025	10 Apr 2025, 16:19

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		12%	+0.26%	$411,790,446	4,373,770	+91,816	+2.1%	$94.15	Q3 2025
30 Sep 2025	call	21%	+21%	$28,245,000	300,000	+300,000	NEW	$94.15	Q3 2025
30 Jun 2025		9.6%	+2%	$225,230,780	4,281,954	+912,255	+27%	$52.60	Q2 2025
31 Mar 2025		6.5%	+3.3%	$141,830,631	3,369,699	+1,679,777		$42.09	Q1 2025
31 Dec 2024		2.5%	-1.1%	$71,061,220	1,689,922	-764,995	-31%	$42.05	Q4 2024
30 Sep 2024		4.3%	+0.76%	$122,647,653	2,454,917	+435,103	+22%	$49.96	Q3 2024
30 Jun 2024		4.6%	+4.2%	$119,512,394	2,019,814	+2,019,814	NEW	$59.17	Q2 2024
31 Dec 2022			-1.5%	$0	0	-564,214	-100%		Q4 2022
30 Sep 2022		1.5%	+0.3%	$11,301,000	564,214	+111,970	+25%	$20.03	Q3 2022
30 Jun 2022		2%	+0.91%	$10,239,000	452,244	+202,506	+81%	$22.64	Q2 2022
31 Mar 2022		1.7%	+1.7%	$6,603,000	249,738	+249,738	NEW	$26.44	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.